Loading data for RGC — first visit, this takes a few seconds.
Regencell Bioscience Holdings Limited (RGC)
NasdaqCM: RGC
· 即時價格 · USD
6.89
+0.41 (6.33%)
收盤價： Sep 09, 2026, 8:00 PM
5.78
-1.20%
盤後: 7:30 PM
股價、關鍵數字和最新消息，都在這一頁。
Regencell Bioscience Holdings Limited（RGC）股價、分析與資料
無可用資料
| 買價 | 5.47 |
| 市值 | 2.89B |
| 營收 (ttm) | n/a |
| 淨利（ttm） | -7.05M |
| 1.43 | |
| -0.01 | |
| n/a | |
| n/a | |
| P/B (ttm) | 2925.00 |
| P/S (ttm) | 0.00 |
| 財報日期 | Jul 16, 2025 |
| 賣價 | 8.26 |
| 成交量 | 659,354 |
| 20 日平均成交量 | 320,352 |
| 開盤價 | 6.43 |
| 前收盤價 | 6.48 |
| 當日區間 | 6.35 - 7.65 |
| 52 週範圍 | 4.51 - 69.00 |
| 分析師 | n/a |
| 目標價 | n/a |
| 股利 | n/a |
| 除息日 | n/a |
關於 RGC
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong....
完整的公司簡介財報驚奇
Regencell Bioscience s 已於 Invalid Date 公布季度財報：
- 營收為 n/a 低於預期 $0, 年增 NaN% 成長.
- 每股盈餘為 低於預期 , 年增 NaN% 成長.
第 1 頁，共 2 頁